1.5(top 50%)
impact factor
2.5K(top 10%)
papers
22.1K(top 10%)
citations
48(top 20%)
h-index
1.5(top 50%)
extended IF
2.6K
all documents
23.7K
doc citations
68(top 20%)
g-index

Top Articles

#TitleJournalYearCitations
1MCP-1, MIP-1, IL-8 and Ischemic Cerebral Tissue Enhance Human Bone Marrow Stromal Cell Migration in Interface CultureHematology2002219
2Thrombocytopenia in patients with severe acute respiratory syndrome (review)Hematology2005156
3Hyposplenism: A comprehensive review. Part I: Basic concepts and causesHematology2007150
4Amplification and overexpression of CKS1B at chromosome band 1q21 is associated with reduced levels of p27 Kip1 and an aggressive clinical course in multiple myelomaHematology2005142
5Mean platelet volume measurement, EDTA or citrate?Hematology2006133
6Gaucher disease epidemiology and natural history: a comprehensive review of the literatureHematology2017123
7Platelet indices in diabetes mellitus: indicators of diabetic microvascular complicationsHematology2011120
8ESR or CRP? A comparison of their clinical utilityHematology2007104
9Bortezomib in combination with thalidomide-dexamethasone for previously untreated multiple myelomaHematology2007101
10Ovarian function after cancer treatment in young women affected by Hodgkin disease (HD)Hematology200797
11NK-cell neoplasms in JapanHematology200595
12Anemia in malignancies: Pathogenetic and diagnostic considerationsHematology201595
13Divalent metal transporter 1Hematology200594
14Hyposplenism: A comprehensive review. Part II: Clinical manifestations, diagnosis, and managementHematology200793
15Alloimmunization and red cell autoimmunization in multitransfused thalassemics of Indian originHematology201090
16Transfusion immunomodulation or TRIM: What does it mean clinically?Hematology200589
17Primary chronic cold agglutinin disease: An update on pathogenesis, clinical features and therapyHematology200780
18Acquired hemophilia A: a review of recent data and new therapeutic optionsHematology201778
19Minimal residual disease and normalization of the bone marrow after long-term treatment with alpha-interferon2b in polycythemia vera. A report on molecular response patterns in seven patients in sustained complete hematological remissionHematology200976
20Duffy blood group and malariaHematology200675
21Cytokines in Sickle Cell DiseaseHematology200374
22Pharmacogenomics ofMDR1/ABCB1Gene: the Influence on Risk and Clinical Outcome of Haematological MalignanciesHematology200474
23A role for niches in hematopoietic cell developmentHematology200572
24Hematological MalignanciesHematology200471
25Roles of the bone marrow niche in hematopoiesis, leukemogenesis, and chemotherapy resistance in acute myeloid leukemiaHematology201869
26The role of long noncoding RNA HOTAIR in the acquired multidrug resistance to imatinib in chronic myeloid leukemia cellsHematology201766
27Granulocyte-Macrophage Colony Stimulating Factor: An Adjuvant for Cancer VaccinesHematology200465
28Auto-immune Haemolytic Anaemia--a High-risk Disorder for Thromboembolism?Hematology200364
29Survey of hematological aspects of Gaucher diseaseHematology200563
30Interferon-γ mediates the immunosuppression of bone marrow mesenchymal stem cells on T-lymphocytes in vitroHematology201863
31Hematological and biochemical parameters as diagnostic and prognostic markers in SARS-COV-2 infected patients of Pakistan: a retrospective comparative analysisHematology202163
32Platelets in sepsisHematology200562
33The myelodysplastic syndromes: Diagnosis, molecular biology and risk assessmentHematology200562
34Red cell alloimmunization in a transfused patient population: a study from a tertiary care hospital in north IndiaHematology200862
35Serum Ferritin as Risk Factor for Veno-occlusive Disease of the Liver. Prospective Cohort StudyHematology199959
36Causes and consequences of the autoimmune lymphoproliferative syndromeHematology200658
37The Role of Inflammation and Leukocytes in the Pathogenesis of Sickle Cell DiseaseHematology200057
38Application of the Molecular Analysis of the T-Cell Receptor Repertoire in the Study of Immune-Mediated Hematologic DiseasesHematology200357
39Alterations of hemostasis after laparoscopic and open surgeryHematology200757
40Resveratrol and quercetin-induced apoptosis of human 232B4 chronic lymphocytic leukemia cells by activation of caspase-3 and cell cycle arrestHematology201356
41Osteoblasts and The Hematopoietic MicroenvironmentHematology199954
42Malaria: a haematological diseaseHematology201254
43Fondaparinux: A potential new therapy for HITHematology200553
44Preeclampsia: Are platelet count and indices useful for its prognostic?Hematology201353
45CD38 as a prognostic marker in CLLHematology200552
46Paroxysmal Cold Haemoglobinuria: A Clinico-Pathological Study of Patients with a Positive Donath-Landsteiner TestHematology199951
47Hemostatic changes in thyroid diseasesHematology200651
48Anti-miR-21 oligonucleotide enhances chemosensitivity of leukemic HL60 cells to arabinosylcytosine by inducing apoptosisHematology201051
49A novel hemostasis assay for the simultaneous measurement of coagulation and fibrinolysisHematology201151
50Biomarkers and early detection of late onset anthracycline-induced cardiotoxicity in childrenHematology201251